Myasthenia Gravis Support Group
Myasthenia gravis (MG) is a neuromuscular disease leading to fluctuating muscle weakness and fatiguability. The hallmark of myasthenia gravis is muscle weakness that increases during periods of activity and improves after periods of rest. Although myasthenia gravis may affect any voluntary muscle, muscles that control eye and eyelid movement, facial expression, and...
The FDA approves the indications, or uses, for a drug based on what evidence is submitted by the manufacturer during clinical testing. Once the drug reaches the market, drugs may be prescribed by the physician for other indications. For expensive drugs, like IVIG, insurance companies try to contain unnecessary expenses using the prior authorization process. Legally, they only have to cover a drug for its approved indications. However, when there is valid evidence for using a drug for a non-approved indication, such as IVIG for MG, your doctor can advocate for you by submitting the reasons the request should be approved. It should include information about your condition, treatments that have been tried and failed, and clinical supporting evidence for using the drug for your condition. IVIG is considered by the medical community to be effective for MG in the literature despite not being part of the FDA approved indications. This is known as a medically accepted indication.
Using the proper terminology by your physician and providing the key information will lead to successful coverage of IVIG with your insurance company. Good luck.
Hugs
L